December Newsmakers


Duke Departments

Barrett and Southwell Named to NASEM Committee on Medical Misinformation (Duke University School of Medicine)
Features Nadine Barrett, PhD

CTSI Translational Impact: Advancing Equity (Annual Report) (CTSI)
Features Nadine Barrett, PhD

Shree Bose Named to Forbes 30 Under 30 for Science (Duke University School of Medicine)
Features Shree Bose (PhD student), Xiling Shen, PhD, and Chris Kontos, MD

Duke Research and Innovation 2021-2022 Annual Report
Features Xiling Shen, PhD (CEO) and David Hsu, MD, PhD

Our 12 Favorite Global Health Stories of 2022 (Duke Global Health Institute)
Features Tomi Akinyemiju, PhD

Gyn Onc Faculty Graduate from ALICE Program (Duke OBGyn)
Features Laura Havrilesky, MD, MHSC; and Angeles Alvarez Secord, MD, MHSc

ALICE 2022 Cohort Graduates Program! (Duke University School of Medicine)
Features Laura Rosenberger, MD; Betty Tong, MD; Laura Havrilesky, MD, MHSC; and Angeles Alvarez Secord, MD, MHSc; Nicole Larrier, MD

WATCH: COEE Holds Community Tobacco Cessation Training: "Ask, Advise, Refer: Strategies for Talking to Cancer Patients about Tobacco Use" Features Steven Patierno, PhD, Megan Keith, MSW, LCSW, and Kearston Ingraham, MPH

A Quiet Place to Reflect (Duke Today)
Features Duke Cancer Center Quiet Room & Kristy Everette Sartin, LRT/CTRS

Ways ‘Microsoft To Do’ Can Keep You Organized (Duke Today)
Features Becca McDaniel

DCI Blog

New Moonshot Initiative: Improving Pediatric Brain Cancer Outcomes in Africa
Features H. Kim Lyerly, MD, and Daniel Landi, MD

A Light in the Darkness: Tree of Hope 2022
Features Robin Famiglietti, PhD

Gersbach Elected NAI Fellow
Features Charles Gersbach, PhD


Two Jewish Women who Broke through Gender Barriers in Science (Aish)
Features Gertrude B. Elion, MSc

Children Treated With Remestemcel-L Show Long-Term Survival Through Four Years in Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD) (Biospace)
*also shared by 20+ outlets including Fox News, Yahoo and WUNC. Some international outlets include Refinery29 Australia, Canadian Insider, and the South Asian Times Online
Features Joanne Kurtzberg, PhD



LISTEN: Salvage Cryoablation for Local Recurrences of Thyroid Cancer (IO Learning)
Features Alan Alper Sag, MD

Caring for an Ostomy (Cure)
Features Stephanie S. Yates, NP

New research finds potentially dangerous cooling agents in E-liquids (Vaping Post)
Features Sven Jordt, PhD

HER2CLIMB: Role of Tucatinib in Treating HER2+ mBC With CNS Disease (Cancer Network/Oncology)
Features Sarah Sammons, MD, and Paul Sperduto, MD

Features Joseph Moore, MD; Nelson Chao, MD, MBA; Michael Kastan, MD, PhD; Scott Antonia, MD, PhD; Meira Epplein, PhD; Cheyenne Corbett, PhD, LMFT; Victor Dzau, MD; Nadine Barrett, PhD; Steve Patierno, PhD; Angelo Moore, PhD, RN.

Oral histories from Duke Cancer Institute (Cancer Letter/Cancer History Project)
Features Hilliard Seigler, MD, and Wolfgang Joklik, MD

Triplet Combinations Could Represent Next Frontier in Frontline Metastatic RCC (Onclive)
Features Michael R. Harrison, MD

Medtronic announces first patient enrolled in U.S. clinical trial for Hugo™ robotic-assisted surgery system (Medtronic)
Features Michael R. Abern, MD

Prostatepedia: Chemotherapy (Prostatepedia Nov/Dec. 2022 issue)
Features Andrew Armstrong, MD, MSc

Andrew Armstrong, MD, MSc, is one of five new associate editors at the Journal of the National Comprehensive Cancer Network (via JNCCN Twitter)

WATCH: SABCS 2022 | The evolution of HER2-low breast cancer from primary to recurrence (VJ Oncology)
Features Rani Bansal, MD

New HER2-Low category spurring efforts to understand breast cancer biology, develop better tests (Precision Oncology News)
Features Rani Bansal, MD

ASH 2022 | ASPEN-05 preliminary data: evorpacept plus azacitidine and venetoclax in patients with AML (VJ Oncology)
Features Harry Erba, MD, PhD

Ziftomenib Demonstrates Activity and Tolerability in Relapsed/Refractory AML (Cancer Network/Oncology)
Features Harry Erba, MD, PhD

Q & A: Shifting paradigms & advancing technology to find I–O biomarkers for Immuno-Oncology: Tools of Tomorrow 2023 feature (Immuno-Oncology Insights 2022)
Features Mustafa Khasraw, MD

Dr. George on the Importance of Understanding Mutations in Prostate Cancer (Onclive)
Features Daniel George, MD

ADCs Represent One of Many Improvements in GU Cancer Treatment (Onclive)
Features Daniel George, MD

Dr. George on the Clinical Benefit of Phenotypic Evaluation in Prostate Cancer (Onclive)
Features Daniel George, MD

Dr. George on the Use of Niraparib for Patients With BRCA and ATM Mutations in mCRPC (OncLive)
Features Daniel George, MD

Women Should Know Their Options, Risks for Future Fertility Before Starting Cancer Treatment (Cure)
Features Clare Meernik, PhD, MPH


NEJM Catalyst top stories of 2022 includes: Goal-Concordant Care: End-of-Life Planning Conversations for All Seriously Ill Patients NEJM Catalyst Nov. 16, 2022 David Casarett, MD, MA, Kristen Lakis, MDiv, LCSW, Jessica E. Ma, MD, Jennifer Gentry, DNP, ANP-BC, GNP, ACHPN, FPCN, Jonathan Fischer, MD, Salam Ibrahim, Yvonne Acker, RN, BSN, and Noppon Pooh Setji, MD 

Estimating CO2 emissions and Direct Power Consumption of LINAC-based External Beam Radiotherapy Advances in Radiation Oncology/ASTRO Dec. 30, 2022 Rachel Shenker, MD; Timothy L. Johnson, PhD; Marcio Ribeiro; Anna Rodrigues, PhD; Junzo Chino, MD.

"More than conquerors": a qualitative analysis of war metaphors for patients with cancer Support Care Cancer Dec 27, 2022 Monica H Bodd, Nikki C Daniels, Hermioni L Amonoo, Tyler Tate, Kris W Herring, Thomas W LeBlanc.

Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer
New England Journal of Medicine Dec. 21, 2022 John H. Strickler, MD, et al.

Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti–PD-1 immunotherapy Science Translational Medicine Nov. 23, 2022 Balamayooran Theivanthiran, Nagendra Yarla, Tarek Haykal, Y.-Van Nguyen, Linda Cao, Michelle Ferreira, Alisha Holtzhausen, Rami Al-Rohil, April K.S. Salama, Georgia M. Beasley, Michael P. Plebanek, Nicholas C. DeVito, and Brent A. Hanks.

Oncological and functional outcomes of men undergoing primary whole gland cryoablation of the prostate: A 20-year experience Cancer Sept. 15, 2022 Wei Phin Tan, MD, Srinath Kotamarti, MD, Emily Chen, MD, Rachael Mahle, MD, Rohith Arcot, MD, Andrew Chang, MD, PhD, Alexandria Ayala, MD, Zoe Michael, MS, Denis Seguier, MD, Thomas J. Polascik MD, FACS.

Modifiable patient-reported factors associated with cancer-screening knowledge and participation in a community-based health assessment  The American Journal of Surgery Nov. 2, 2022 Oluwadamilola M Fayanju, Taofik Oyekunle, Samantha M Thomas, Kearston L Ingraham, Laura J Fish, Rachel A Greenup, Kevin C Oeffinger, S Yousuf Zafar, Terry Hyslop, E Shelley Hwang, Steven R Patierno, Nadine J Barrett

Previous DCI Newsmakers